İ. Çok Et Al. , "The mutagenic potential assessment of the major impurity of hypertension drug hydrochlorothiazide," 49th Congress of the European-Societies-of-Toxicology (EUROTOX) , vol.221, Interlaken, Switzerland, 2013
Çok, İ. Et Al. 2013. The mutagenic potential assessment of the major impurity of hypertension drug hydrochlorothiazide. 49th Congress of the European-Societies-of-Toxicology (EUROTOX) , (Interlaken, Switzerland).
Çok, İ., Emerce, E., Sari, S., & Bostanci, O., (2013). The mutagenic potential assessment of the major impurity of hypertension drug hydrochlorothiazide . 49th Congress of the European-Societies-of-Toxicology (EUROTOX), Interlaken, Switzerland
Çok, İSMET Et Al. "The mutagenic potential assessment of the major impurity of hypertension drug hydrochlorothiazide," 49th Congress of the European-Societies-of-Toxicology (EUROTOX), Interlaken, Switzerland, 2013
Çok, İSMET Et Al. "The mutagenic potential assessment of the major impurity of hypertension drug hydrochlorothiazide." 49th Congress of the European-Societies-of-Toxicology (EUROTOX) , Interlaken, Switzerland, 2013
Çok, İ. Et Al. (2013) . "The mutagenic potential assessment of the major impurity of hypertension drug hydrochlorothiazide." 49th Congress of the European-Societies-of-Toxicology (EUROTOX) , Interlaken, Switzerland.
@conferencepaper{conferencepaper, author={İSMET ÇOK Et Al. }, title={The mutagenic potential assessment of the major impurity of hypertension drug hydrochlorothiazide}, congress name={49th Congress of the European-Societies-of-Toxicology (EUROTOX)}, city={Interlaken}, country={Switzerland}, year={2013}}